Michael Barbella, Managing Editor06.17.22
physIQ has appointed John Wilson as senior vice president and general manager of Life Sciences, and Chris Englerth as vice president of Marketing.
“We welcome John and Chris. They bring proven performance and well-honed skills to their respective areas of expertise,” said Gary Conkright, physIQ chairman, CEO, and founder. “As part of our leadership team, they join us in advancing our mission to partner with leading global organizations to build a digital healthcare ecosystem that delivers innovation and improved health outcomes while reducing costs.”
physIQ’s U.S. Food and Drug Administration (FDA)-cleared, AI-based technology platform uses medical-grade wearable devices to continuously monitor patients in decentralized clinical trials and in hospital at home settings. Through the remote capture of near real-time biosensor data, life sciences and healthcare organizations gain highly personalized, clinically valid, actionable insights to guide drug development and patient care.
Wilson is focused on continuing to lead customer-facing initiatives to achieve the corporate goals of the physIQ life sciences business. He sets and oversees the vision and growth of the physIQ life sciences practice, builds out the sales pipeline, and maintains the high quality of existing relationships with global pharma/biotech clients, clinical research organizations, and industry partners.
“I am privileged to be part of the talented team who helped to pioneer and revolutionize digital health. The continuum between life sciences and healthcare is maturing, and physIQ’s technology converges personalized monitoring with personalized medicine to bring safer, more effective drugs to market faster and help patients live healthier lives,” Wilson said.
Wilson’s credentials span over two decades in sales, solution consulting and operations leadership positions for numerous global companies, including Oracle, Medidata Solutions and Veeva systems. He earned a bachelor of science degree in electrical engineering from Clarkson University.
Englerth brings almost 25 years of experience in advertising, communications, and marketing predominantly for healthcare and life sciences organizations. In his role at physIQ, he will take the lead on all marketing efforts in support of business development and communications with stakeholders and prospective partners.
“I am excited to play an integral role building awareness and adoption of our enterprise-ready cloud-based physIQ platform. Proactive, predictive, personalized digital health solutions enhance access to better and more affordable healthcare—yielding benefits for patients, providers, and researchers,” Englerth added.
Previously, Englerth led global marketing efforts at Phlexglobal (now part of PharmaLex) and Bioclinica (now Clario) and held marketing positions of increasing responsibility at Apria Healthcare, as well as for the American Red Cross. He earned a bachelor of arts degree in english from Pennsylvania State University.
physIQ develops digital medicine technology, generating health insights using continuous wearable biosensor data and advanced analytics. Its enterprise-ready cloud platform continuously collects and processes data from wearable biosensor using a deep portfolio of FDA-cleared analytics. The company has published one of the most rigorous clinical studies to date in digital medicine and are pioneers in developing, validating, and achieving regulatory approval of Artificial Intelligence-based analytics. With applications in both clinical trial support and healthcare, physIQ is transforming continuous physiological data into insight for health systems, payers, and companies.
“We welcome John and Chris. They bring proven performance and well-honed skills to their respective areas of expertise,” said Gary Conkright, physIQ chairman, CEO, and founder. “As part of our leadership team, they join us in advancing our mission to partner with leading global organizations to build a digital healthcare ecosystem that delivers innovation and improved health outcomes while reducing costs.”
physIQ’s U.S. Food and Drug Administration (FDA)-cleared, AI-based technology platform uses medical-grade wearable devices to continuously monitor patients in decentralized clinical trials and in hospital at home settings. Through the remote capture of near real-time biosensor data, life sciences and healthcare organizations gain highly personalized, clinically valid, actionable insights to guide drug development and patient care.
Wilson is focused on continuing to lead customer-facing initiatives to achieve the corporate goals of the physIQ life sciences business. He sets and oversees the vision and growth of the physIQ life sciences practice, builds out the sales pipeline, and maintains the high quality of existing relationships with global pharma/biotech clients, clinical research organizations, and industry partners.
“I am privileged to be part of the talented team who helped to pioneer and revolutionize digital health. The continuum between life sciences and healthcare is maturing, and physIQ’s technology converges personalized monitoring with personalized medicine to bring safer, more effective drugs to market faster and help patients live healthier lives,” Wilson said.
Wilson’s credentials span over two decades in sales, solution consulting and operations leadership positions for numerous global companies, including Oracle, Medidata Solutions and Veeva systems. He earned a bachelor of science degree in electrical engineering from Clarkson University.
Englerth brings almost 25 years of experience in advertising, communications, and marketing predominantly for healthcare and life sciences organizations. In his role at physIQ, he will take the lead on all marketing efforts in support of business development and communications with stakeholders and prospective partners.
“I am excited to play an integral role building awareness and adoption of our enterprise-ready cloud-based physIQ platform. Proactive, predictive, personalized digital health solutions enhance access to better and more affordable healthcare—yielding benefits for patients, providers, and researchers,” Englerth added.
Previously, Englerth led global marketing efforts at Phlexglobal (now part of PharmaLex) and Bioclinica (now Clario) and held marketing positions of increasing responsibility at Apria Healthcare, as well as for the American Red Cross. He earned a bachelor of arts degree in english from Pennsylvania State University.
physIQ develops digital medicine technology, generating health insights using continuous wearable biosensor data and advanced analytics. Its enterprise-ready cloud platform continuously collects and processes data from wearable biosensor using a deep portfolio of FDA-cleared analytics. The company has published one of the most rigorous clinical studies to date in digital medicine and are pioneers in developing, validating, and achieving regulatory approval of Artificial Intelligence-based analytics. With applications in both clinical trial support and healthcare, physIQ is transforming continuous physiological data into insight for health systems, payers, and companies.